BridgeMD
New treatment option for Chronic Subdural Hematomas
Official title Prospective Clinical Investigation on Infection as a Cause of Chronic Subdural Hematoma.
ClinicalTrials.gov ID: NCT07556991
What this study is testing
What is Amoxicillin + clavulanic acid?
Amoxicillin + clavulanic acid is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for chronic subdural hematomas.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Chronic subdural hematoma (cSDH) is a very common disease, primarily affecting older people, and is associated with significant morbidity and mortality. The incidence described in the literature is approximately 5 per 100,000/year, but it occurs more frequently in the elderly, with up to 58 per 100,000/year.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \>18 years of age
- surgical treatment of chronic subdural hematoma
You likely can't join if
- prior or current antibiotic treatment
- infection
- recurrent chronic subdural hematoma
- conservatively treated chronic subdural hematoma
The study team makes the final eligibility decision.
Where it's taking place
- Rostock, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rostock, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.